1. Home
  2. TOVX vs KLTOW Comparison

TOVX vs KLTOW Comparison

Compare TOVX & KLTOW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TOVX
  • KLTOW
  • Stock Information
  • Founded
  • TOVX 2001
  • KLTOW N/A
  • Country
  • TOVX United States
  • KLTOW United States
  • Employees
  • TOVX N/A
  • KLTOW N/A
  • Industry
  • TOVX Biotechnology: Pharmaceutical Preparations
  • KLTOW Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • TOVX Health Care
  • KLTOW Health Care
  • Exchange
  • TOVX Nasdaq
  • KLTOW Nasdaq
  • Market Cap
  • TOVX 3.5M
  • KLTOW N/A
  • IPO Year
  • TOVX 2006
  • KLTOW 2022
  • Fundamental
  • Price
  • TOVX $1.14
  • KLTOW $0.03
  • Analyst Decision
  • TOVX Strong Buy
  • KLTOW
  • Analyst Count
  • TOVX 1
  • KLTOW 0
  • Target Price
  • TOVX $6.00
  • KLTOW N/A
  • AVG Volume (30 Days)
  • TOVX 96.3K
  • KLTOW N/A
  • Earning Date
  • TOVX 11-12-2024
  • KLTOW N/A
  • Dividend Yield
  • TOVX N/A
  • KLTOW N/A
  • EPS Growth
  • TOVX N/A
  • KLTOW N/A
  • EPS
  • TOVX N/A
  • KLTOW N/A
  • Revenue
  • TOVX N/A
  • KLTOW N/A
  • Revenue This Year
  • TOVX N/A
  • KLTOW N/A
  • Revenue Next Year
  • TOVX N/A
  • KLTOW N/A
  • P/E Ratio
  • TOVX N/A
  • KLTOW N/A
  • Revenue Growth
  • TOVX N/A
  • KLTOW N/A
  • 52 Week Low
  • TOVX $1.14
  • KLTOW N/A
  • 52 Week High
  • TOVX $17.00
  • KLTOW N/A
  • Technical
  • Relative Strength Index (RSI)
  • TOVX 36.15
  • KLTOW N/A
  • Support Level
  • TOVX $1.23
  • KLTOW N/A
  • Resistance Level
  • TOVX $1.21
  • KLTOW N/A
  • Average True Range (ATR)
  • TOVX 0.07
  • KLTOW 0.00
  • MACD
  • TOVX 0.01
  • KLTOW 0.00
  • Stochastic Oscillator
  • TOVX 0.00
  • KLTOW 0.00

About TOVX Theriva Biologics Inc.

Theriva Biologics Inc is a clinical-stage pharmaceutical company developing a novel oncolytic adenovirus (OV) platform to address devastating cancers with high unmet needs. It is a lead clinical-stage program VCN-01, designed to break down the tumor stroma, and its preclinical-stage program VCN-11 leverages its proprietary Albumin Shield Technology to protect systemically administered oncolytic viruses from the host immune system.

About KLTOW Klotho Neurosciences Inc. Warrant

Klotho Neurosciences Inc is in the development of patented, novel disease-modifying technologies targeting the brain and central nervous system (CNS) that are seen as key developments in treating neurodegenerative and age-related disorders.

Share on Social Networks: